The Clinical Neuropsychologist,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 29
Published: Aug. 23, 2024
The
coronavirus
disease-2019
(COVID-19)
pandemic,
caused
by
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2),
has
had
a
profound
global
impact
on
individual
health
and
well-being
in
adults
children.
While
most
fully
recover
from
COVID-19,
relatively
large
subgroup
continues
to
experience
persistent
physical,
cognitive,
emotional/behavioral
symptoms
beyond
the
initial
infection
period.
World
Health
Organization
termed
this
phenomenon
"Post-COVID-19
Condition"
(PCC),
better
known
as
"Long
COVID."
Due
cognitive
psychosocial
symptoms,
neuropsychologists
often
assess
recommend
treatment
for
individuals
with
Long
COVID.
However,
guidance
neuropsychologists'
involvement
clinical
care,
policy-making,
research
not
yet
been
developed.
authors
of
manuscript
convened
address
critical
gap
develop
working
patients
presenting
Frontiers in Medicine,
Journal Year:
2023,
Volume and Issue:
10
Published: June 2, 2023
Some
patients
remain
unwell
for
months
after
"recovering"
from
acute
COVID-19.
They
develop
persistent
fatigue,
cognitive
problems,
headaches,
disrupted
sleep,
myalgias
and
arthralgias,
post-exertional
malaise,
orthostatic
intolerance
other
symptoms
that
greatly
interfere
with
their
ability
to
function
can
leave
some
people
housebound
disabled.
The
illness
(Long
COVID)
is
similar
myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS)
as
well
persisting
illnesses
follow
a
wide
variety
of
infectious
agents
following
major
traumatic
injury.
Together,
these
are
projected
cost
the
U.S.
trillions
dollars.
In
this
review,
we
first
compare
ME/CFS
Long
COVID,
noting
considerable
similarities
few
differences.
We
then
in
extensive
detail
underlying
pathophysiology
two
conditions,
focusing
on
abnormalities
central
autonomic
nervous
system,
lungs,
heart,
vasculature,
immune
gut
microbiome,
energy
metabolism
redox
balance.
This
comparison
highlights
how
strong
evidence
each
abnormality,
illness,
helps
set
priorities
future
investigation.
review
provides
current
road
map
literature
biology
both
illnesses.
Cardiovascular Diabetology,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Feb. 20, 2024
Abstract
Early
since
the
onset
of
COVID-19
pandemic,
medical
and
scientific
community
were
aware
extra
respiratory
actions
SARS-CoV-2
infection.
Endothelitis,
hypercoagulation,
hypofibrinolysis
identified
in
patients
as
subsequent
responses
endothelial
dysfunction.
Activation
barrier
may
increase
severity
disease
contribute
to
long-COVID
syndrome
post-COVID
sequelae.
Besides,
it
cause
alterations
primary,
secondary,
tertiary
hemostasis.
Importantly,
these
have
been
highly
decisive
evolution
infected
also
diagnosed
with
diabetes
mellitus
(DM),
who
showed
previous
In
this
review,
we
provide
an
overview
potential
triggers
activation
related
under
diabetic
milieu.
Several
mechanisms
are
induced
by
both
viral
particle
itself
immune-defensive
response
(i.e.,
NF-κB/NLRP3
inflammasome
pathway,
vasoactive
peptides,
cytokine
storm,
NETosis,
complement
system).
Alterations
coagulation
mediators
such
factor
VIII,
fibrin,
tissue
factor,
von
Willebrand
factor:
ADAMST-13
ratio,
kallikrein-kinin
or
plasminogen-plasmin
systems
reported.
Moreover,
imbalance
thrombotic
thrombolytic
(tPA,
PAI-I,
fibrinogen)
factors
favors
hypercoagulation
hypofibrinolysis.
context
DM,
can
be
exacerbated
leading
higher
loss
However,
a
series
therapeutic
strategies
targeting
activated
endothelium
specific
antibodies
inhibitors
against
thrombin,
key
cytokines,
X,
system,
system
might
represent
new
opportunities
address
hypercoagulable
state
present
DM.
Antidiabetics
ameliorate
dysfunction,
inflammation,
platelet
aggregation.
By
improving
microvascular
pathology
subjects,
associated
comorbidities
risk
mortality
could
reduced.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(13), P. 10458 - 10458
Published: June 21, 2023
Long
COVID
(LC)
encompasses
a
constellation
of
long-term
symptoms
experienced
by
at
least
10%
people
after
the
initial
SARS-CoV-2
infection,
and
so
far
it
has
affected
about
65
million
people.
The
etiology
LC
remains
unclear;
however,
many
pathophysiological
pathways
may
be
involved,
including
viral
persistence;
chronic,
low-grade
inflammatory
response;
immune
dysregulation
defective
reactivation
latent
viruses;
autoimmunity;
persistent
endothelial
dysfunction
coagulopathy;
gut
dysbiosis;
hormonal
metabolic
dysregulation;
mitochondrial
dysfunction;
autonomic
nervous
system
dysfunction.
There
are
no
specific
tests
for
diagnosis
LC,
clinical
features
laboratory
findings
biomarkers
not
specifically
relate
to
LC.
Therefore,
is
paramount
importance
develop
validate
that
can
employed
prediction,
prognosis
its
therapeutic
response,
although
this
effort
hampered
challenges
pertaining
non-specific
nature
majority
manifestations
in
spectrum,
small
sample
sizes
relevant
studies
other
methodological
issues.
Promising
candidate
found
some
patients
markers
systemic
inflammation,
acute
phase
proteins,
cytokines
chemokines;
reflecting
persistence,
herpesviruses
endotheliopathy,
coagulation
fibrinolysis;
microbiota
alterations;
diverse
proteins
metabolites;
biomarkers;
cerebrospinal
fluid
biomarkers.
At
present,
there
only
two
reviews
summarizing
they
do
cover
entire
umbrella
current
biomarkers,
their
link
etiopathogenetic
mechanisms
or
diagnostic
work-up
comprehensive
manner.
Herein,
we
aim
appraise
synopsize
available
evidence
on
typical
classification
based
pathogenetic
main
symptomatology
frame
epidemiological
aspects
syndrome
furthermore
assess
limitations
as
well
potential
implications
interventions.
The Neuroscientist,
Journal Year:
2023,
Volume and Issue:
30(4), P. 421 - 439
Published: Sept. 11, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
the
causative
agent
of
disease
2019
(COVID-19),
could
affect
brain
structure
and
function.
SARS-CoV-2
can
enter
through
different
routes,
including
olfactory,
trigeminal,
vagus
nerves,
blood
immunocytes.
may
also
from
peripheral
a
disrupted
blood-brain
barrier
(BBB).
The
neurovascular
unit
in
brain,
composed
neurons,
astrocytes,
endothelial
cells,
pericytes,
protects
parenchyma
by
regulating
entry
substances
blood.
astrocytes
highly
express
angiotensin
converting
enzyme
(ACE2),
indicating
that
BBB
be
disturbed
lead
to
derangements
tight
junction
adherens
proteins.
This
leads
increased
permeability,
leakage
components,
movement
immune
cells
into
parenchyma.
cross
microvascular
an
ACE2
receptor–associated
pathway.
exact
mechanism
dysregulation
COVID-19/neuro-COVID
is
not
clearly
known,
nor
development
long
COVID.
Various
biomarkers
indicate
severity
neurologic
complications
COVID-19
help
objectively
diagnose
those
developing
review
highlights
importance
disruption,
as
well
some
potentially
useful
COVID-19,
COVID/neuro-COVID.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: May 28, 2024
The
novel
coronavirus
disease
2019
(COVID-19)
pandemic
outbreak
caused
by
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
has
garnered
unprecedented
global
attention.
It
over
2.47
million
deaths
through
various
syndromes
such
as
distress,
hypercoagulability,
and
multiple
organ
failure.
viral
invasion
proceeds
the
ACE2
receptor,
expressed
in
cell
types,
some
patients
serious
damage
to
tissues,
organs,
immune
cells,
microbes
that
colonize
gastrointestinal
tract
(GIT).
Some
who
survived
SARS-CoV-2
infection
have
developed
months
of
persistent
long-COVID-19
symptoms
or
post-acute
sequelae
COVID-19
(PASC).
Diagnosis
these
revealed
biological
effects,
none
which
are
mutually
exclusive.
However,
severity
also
depends
on
numerous
comorbidities
obesity,
age,
diabetes,
hypertension
care
must
be
taken
with
respect
other
morbidities,
host
immunity.
Gut
microbiota
relation
immunopathology
is
considered
evolve
progression
via
mechanisms
biochemical
metabolism,
exacerbation
inflammation,
intestinal
mucosal
secretion,
cytokine
storm,
immunity
regulation.
Therefore,
modulation
gut
microbiome
equilibrium
food
supplements
probiotics
remains
a
hot
topic
current
research
debate.
In
this
review,
we
discuss
complications
physio-pathological
effects
infection,
GIT
response,
therapeutic
pharmacological
strategies.
We
summarize
targets
probiotics,
their
limitations,
efficacy
preclinical
clinical
drugs
effectively
inhibit
spread
SARS-CoV-2.
Acta Neuropsychiatrica,
Journal Year:
2024,
Volume and Issue:
36(3), P. 172 - 184
Published: April 4, 2024
Persistent
infection
with
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
reactivation
of
dormant
viruses,
and
immune-oxidative
responses
are
involved
in
long
COVID.
Alimentary Pharmacology & Therapeutics,
Journal Year:
2024,
Volume and Issue:
59(10), P. 1260 - 1270
Published: March 6, 2024
Summary
Background
Brain
fog
is
a
subjective
cognitive
impairment
commonly
reported
in
coeliac
disease.
A
standardised
tool
to
define
and
assess
it
an
important
unmet
need.
Aims
To
develop
patient‐informed
brain
disease
support
clinical
care,
research
drug
development.
Methods
pilot
online
study
defined
patient
descriptors
of
fog.
second
evaluated
the
factor
structure
performance
scale
across
two‐time
points
(‘Now’
‘Past
week’).
One
month
later,
participants
were
invited
repeat
with
two
processing
tests,
Stroop
task
trail
making
test.
Results
Among
adults
treated
disease,
37
(91.9%
F)
participated
510
(88.8%
whom
99
repeated
1
later
51
completing
testing.
The
most
common
‘difficulty
focusing’,
thinking’
finding
right
words
communicating’.
12‐item
reflects
‘cognitive
impairment’
‘somatic
affective
experience’
demonstrates
strong
psychometric
properties.
It
tracked
patients
report
being
present
or
absent
points.
did
not
significantly
correlate
tests.
Conclusion
assessment
severity
first
outcomes
measuring
brief
validated
for
time‐based
formats.
Further
coupling
biomarker
discovery
needed
confirm
its
validity
as
predictor
performance.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(2), P. 304 - 304
Published: Jan. 16, 2025
Background:
Long
COVID
(LC)
is
characterized
by
persistent
symptoms
at
least
3
months
after
a
SARS-COV-2
infection.
LC
has
been
associated
with
fungal
translocation,
gut
dysfunction,
and
enhanced
systemic
inflammation.
Currently,
there
no
approved
treatment
for
this
condition.
The
anti-inflammatory
effect
of
vitamins
K2
D3
was
shown
to
help
attenuate
the
course
acute
COVID-19
Objective
hypothesis:
This
trial
aims
investigate
effects
K2/D3
on
symptoms,
as
well
inflammatory
markers,
in
people
established
long
COVID.
Our
hypothesis
that
attenuating
inflammation,
will
improve
symptoms.
Methods:
single-site
randomized
controlled
study
enrolled
adults
experiencing
≥2
moderate
RECOVER
Research
Index
number
type
were
considered.
Participants
2:1
daily
240
µg
(pure
MK-7
form)
2000
UI
vitamin
or
standard
care
(SOC)
24
weeks.
endpoints
changes
symptomatology
select
inflammatory,
metabolic,
biomarkers
Results:
We
151
participants
(n
=
98
received
vit
53
SOC).
median
age
46
years;
71%
female
29%
non-white.
Baseline
demographics
balanced
between
groups.
At
weeks,
active
group
only
had
sharp
increase
25(OH)
D,
indicating
good
adherence.
In
arm,
7.1%
decrease
proportion
who
an
≥12
(vs.
7.2%
SOC
group;
p
0.01).
average
remained
stable
arm
but
increased
(p
0.03).
Additionally,
reductions
oxidized
LDL,
markers
sTNF-RI
sCD163,
translocation
marker
(1,3)-β-d-glucan
observed
compared
<
0.01)
over
Conclusions:
Vitamins
improved
Index,
several
markers.
provide
promising
safe
intervention
suffering
from
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Feb. 12, 2025
The
emergence
of
the
COVID-19
pandemic
made
it
critical
to
understand
immune
and
inflammatory
responses
SARS-CoV-2
virus.
It
became
increasingly
recognized
that
response
was
a
key
mediator
illness
severity
its
mechanisms
needed
be
better
understood.
Early
infection
both
tissue
cells,
such
as
macrophages,
leading
pyroptosis-mediated
inflammasome
production
in
an
organ
system
for
systemic
oxygenation
likely
plays
central
role
morbidity
wrought
by
SARS-CoV-2.
Delayed
transcription
Type
I
III
interferons
may
lead
early
disinhibition
viral
replication.
Cytokines
interleukin-1
(IL-1),
IL-6,
IL-12,
tumor
necrosis
factor
α
(TNFα),
some
which
produced
through
involving
nuclear
kappa
B
(NF-κB),
contribute
hyperinflammatory
state
patients
with
severe
COVID-19.
Lymphopenia,
more
apparent
among
natural
killer
(NK)
CD8+
T-cells,
B-cells,
can
disease
reflect
direct
cytopathic
effects
or
end-organ
sequestration.
Direct
activation
endothelial
cells
mechanism
systems
are
impacted.
In
this
context,
endovascular
neutrophil
extracellular
trap
(NET)
formation
microthrombi
development
seen
lungs
other
organs
throughout
body,
heart,
gut,
brain.
kidney
most
impacted
extrapulmonary
owing
high
concentration
ACE2
exposure
kidney,
acute
tubular
injury,
myofibroblast
activation,
collapsing
glomerulopathy
select
populations
account
COVID-19-related
AKI
CKD
development.
COVID-19-associated
nephropathy
(COVAN),
particular,
mediated
IL-6
signal
transducer
activator
3
(STAT3)
signaling,
suggesting
connection
between
chronic
disease.
Chronic
manifestations
also
include
conditions
like
Multisystem
Inflammatory
Syndrome
Children
(MIS-C)
Adults
(MIS-A)
post-acute
sequelae
(PASC),
spectrum
clinical
presentations
persistent
dysregulation.
lessons
learned
those
undergoing
continued
study
have
broad
implications
understanding
infections’
immunologic
consequences
beyond
coronaviruses.
Frontiers in Cellular Neuroscience,
Journal Year:
2022,
Volume and Issue:
16
Published: May 9, 2022
Although
myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS)
has
a
specific
and
distinctive
profile
of
clinical
features,
the
disease
remains
an
enigma
because
causal
explanation
pathobiological
matrix
is
lacking.
Several
potential
mechanisms
have
been
identified,
including
immune
abnormalities,
inflammatory
activation,
mitochondrial
alterations,
endothelial
muscular
disturbances,
cardiovascular
anomalies,
dysfunction
peripheral
central
nervous
systems.
Yet,
it
unclear
whether
how
these
pathways
may
be
related
orchestrated.
Here
we
explore
hypothesis
that
common
denominator
processes
in
ME/CFS
system
due
to
impaired
or
pathologically
reactive
neuroglia
(astrocytes,
microglia
oligodendrocytes).
We
will
test
this
by
reviewing,
reference
current
literature,
two
most
salient
widely
accepted
features
ME/CFS,
investigating
might
linked
dysfunctional
neuroglia.
From
review
conclude
multifaceted
pathobiology
attributable
unifying
manner
neuroglial
dysfunction.
Because
key
–
post
exertional
malaise
decreased
cerebral
blood
flow
are
also
recognized
subset
patients
with
post-acute
sequelae
COVID,
suggest
our
findings
pertinent
entity.